2 companies
argenx
Market Cap: €43.2b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€705.60
7D
0.5%
1Y
27.9%
Melexis
Market Cap: €2.5b
Designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle East, Africa, the Asia Pacific, and North and Latin America.
New
MELE
€62.50
7D
0.7%
1Y
4.3%